IRMD Stock: Price, Earnings History and SEC Filings
IRADIMED CORPORATION (IRMD) last traded at $76.68, down 10.57% on the latest session and down 11.1% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.41 against an analyst estimate of $0.42, a miss of 2.4%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
IRMD earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Jul 31, 2026 | $0.41 | $0.42 | -2.38% |
| Mar 2026 | May 1, 2026 | $0.45 | $0.41 | +9.76% |
| Dec 2025 | Feb 10, 2026 | $0.50 | $0.44 | +13.64% |
| Sep 2025 | Nov 3, 2025 | $0.43 | $0.43 | +0.00% |
IRMD beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
How IRMD reacts to earnings
Across its last 8 earnings releases, IRMD moved 7.6% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-30 | Before open | -10.57% |
| 2026-05-01 | Before open | +4.45% |
| 2026-02-10 | Before open | +9.57% |
| 2025-11-03 | Before open | +9.50% |
| 2025-08-01 | Before open | +13.42% |
| 2025-05-05 | Before open | -2.19% |
| 2025-02-13 | Before open | -8.39% |
| 2025-01-10 | Before open | -2.78% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
IRMD financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $84M | $22M | $17M | 26.8% | $1.75 |
| 2024 | $73M | $19M | $18M | 26.3% | $1.50 |
| 2023 | $66M | $17M | $6M | 26.2% | $1.35 |
| 2022 | $53M | $13M | $9M | 24.1% | $1.02 |
| 2021 | $42M | $9M | $11M | 22.3% | $0.74 |
| 2020 | $32M | $1M | $5M | 4.3% | $0.11 |
| 2019 | $39M | $10M | $10M | 25.0% | $0.78 |
| 2018 | $30M | $6M | $7M | 20.7% | $0.52 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for IRMD
- 10-Q · Oct 30, 2026
- 8-K · Oct 30, 2026Results of operations, Financial statements and exhibits
- 10-Q · Jul 31, 2026
- 8-K · Jul 31, 2026Other events
- 8-K · Jun 24, 2026Shareholder vote
- 10-Q · May 1, 2026
- 8-K · May 1, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 30, 2026
- 10-K · Mar 6, 2026
- 8-K · Feb 10, 2026Results of operations, Financial statements and exhibits
Insider filing activity
IRMD insiders filed 2 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
IRMD news
- IRadimed (IRMD) Stock Drops After Q3 Earnings Fail To Clear High BarNov 1, 2026 · finance.yahoo.com
- Is IRADIMED (IRMD) Fully Priced Based On Future Cash Flow?Oct 31, 2026 · finance.yahoo.com
- IRadimed Corporation Q3 2026 Earnings Call SummaryOct 30, 2026 · app.moby.co
- Iradimed (IRMD) Q3 2026 Earnings Call TranscriptOct 30, 2026 · fool.com
- What iRadimed (IRMD) Said on Its Q3 Earnings CallOct 30, 2026 · marketbeat.com
- IRadimed: Q3 Earnings SnapshotOct 30, 2026 · finance.yahoo.com
- IRADIMED CORPORATION Reports Third Quarter 2026 Financial ResultsOct 30, 2026 · finance.yahoo.com
- IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026Oct 23, 2026 · finance.yahoo.com
About IRADIMED CORPORATION
IRADIMED CORPORATION (IRMD) is a US-listed public company on Nasdaq. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in DE. Its fiscal year ends in December.